Antidepressants during pregnancy and lactation: Defining exposure and treatment issues

Seminars in Perinatology

Volumn 25, Issue 3, 2001, Pages 177-190

  Jeffrey Newport, D ^a   Wilcox, Molly M ^a   Stowe, Zachary N ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

BREAST MILK; CONFERENCE PAPER; DEPRESSION; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG INDUCED DISEASE; DYSTHYMIA; FEMALE; HUMAN; LACTATION; MATHEMATICAL MODEL; NONHUMAN; PANIC; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIMATE; PRIORITY JOURNAL; STRESS;

EID: 0034990838     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2001.24901     Document Type: Conference Paper

References (162)

1. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy
2. Cortisol concentrations in the breast milk of women with major depression
3. Placental passage of antidepressants
4. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women
5. Psychotropic medications in lactation
6. Mood disorders during pregnancy and lactation: Defining exposure and treatment issues
7. Progression of depression in the prenatal and postpartum periods
8. Causal attributions and perinatal depression
9. Depressive attributional style and depression following childbirth
10. Predicting depressive symptomatology: Cognitive-behavioural models and postpartum depression
11. Psychiatric disorder in pregnancy and the first postnatal year
12. A prospective study of emotional disorders in childbearing women
13. Prospective study of postpartum depression: Prevalence, course, and predictive factors
14. Screening methods for postpartum depression
15. A standardized interview that differentiates pregnancy and postpartum symptoms from perinatal clinical depression
16. Depression in women: Implications for health care research
17. Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum
18. The prediction of major depression in women: Toward an integrated etiologic model
19. Postpartum depression: Identifying women at risk
20. The maternity blues in post-partum and post-operative women
21. Maternity blues: Phenomena and relationship to later postpartum depression
22. Maternity blues: Detection and measurement by questionnaire
23. Prospective study of postpartum blues: Biologic and psychosocial factors
24. Course and correlates of postpartum depression during the transition to parenthood
25. Postnatal depression: A review of recent literature
26. Course and recurrence of postnatal depression evidence for the specificity of the diagnostic concept
27. Nonpsychotic postpartum depression among adolescent mothers
28. Women at risk for postpartum-onset major depression
29. The use of rating scales in postpartum depression
30. The nosology and prognosis of puerperal psychosis: A review
31. Environmental noise and human prenatal growth
32. The relationship between psychological distress during pregnancy and birth weight for gestational age
33. Prenatal stressors of human life affect fetal brain development
34. Maternal corticotropin-releasing hormone is increased with impending preterm birth
35. Maternal depressive symptoms and the risk of poor pregnancy outcome
36. Self-reported depression and negative pregnancy outcomes
37. The effect of anxiety and depression during pregnancy on obstetric complications
38. Child psychiatric sequelae of maternal war stress
39. Follow-up study from birth of the effects of prenatal stresses
40. Depression in first-time mothers: Mother-infant interaction and depression chronicity
41. Depressive symptoms during pregnancy: Relationship to poor health behaviors
42. Mode of delivery and subsequent stress response
43. Prenatal depression effects on neonates
44. Serum prolactin levels and maintenance of progeny by prenatally-stressed female offspring
45. Growth and development following prenatal stress exposure in primates: An examination of ontogenetic vulnerability
46. The effects of prenatal stress on rat offsprings' learning ability
47. Acute and repeated gestational stress affect offspring learning and activity in rats
48. Effects of gestational undernutrition, stress and diazepam treatment on spatial discrimination learning and retention in young rats
49. The effects of prenatal exposure to predictable or unpredictable stress on early development in the rat
50. Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity
51. Prenatal stress effects on functional development of the offspring
52. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: Correlation with stress-induced corticosterone secretion
53. Prenatal stress effects on exploratory activity and stress-induced analgesia in rats
54. Role of experimental conditions in determining differences in exploratory behavior of prenatally stressed rats
55. Chronic prenatal stress affects development and behavioral depression in rats
56. Neonatal handling reverses behavioral abnormalities induced in rats by prenatal stress
57. Prenatal exposure to predictable and unpredictable novelty stress and oxytocin treatment affects offspring development and behavior in rats
58. Effects of prenatal stress on vulnerability to stress in prepubertal and adult rats
59. Prenatal stress exposure alters postnatal behavioral expression under conditions of novelty challenge in rhesus monkey infants
60. Prenatal stress has long-term effects on behavioral responses to stress in juvenile rhesus monkeys
61. Prenatal stress: Consequences of glucocorticoids on hippocampal development and function
62. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats
63. Early developmental and temporal characteristics of stress-induced secretion of pituitary-adrenal hormones in prenatally stress rat pups
64. The effects of prenatal stress on the development of hypothalamic paraventricular neurons in fetal rats
65. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary-adrenal system in female rats
66. Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats
67. Prenatal stress: Effects on brain biogenic amine and plasma corticosterone levels
68. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress
69. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress
70. Prenatal stress affects mother-infant interaction in Norway rats
71. Prenatal stress eliminates differential maternal attention to male offspring in Norway rats
72. Permanent dopaminergic alterations in the nucleus accumbens after prenatal stress
73. Motor lateralization, behavioral despair and dopaminergic brain asymmetry after prenatal stress
74. Prenatal stress impairs maternal behavior in a conflict situation and reduces hippocampal benzodiazepine receptors
75. Prenatal stress: Effect on development of rat brain adrenergic receptors
76. Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens
77. Maternal stress induces synaptic loss and developmental disabilities of offspring
78. Maternal stress increases fetal brain and neonatal cerebral cortex 5-hydroxytryptamine synthesis in rats: A possible mechanism by which stress influences brain development
79. Effects of maternal stress during different gestational periods on the serotonergic system in adult rat offspring
80. Prenatal stress increases the behavioral response to serotonin agonists and alters open field behavior in the rat
81. Psychopathology in the children (ages 6-18) of depressed and normal parents
82. Depression and the parenting of young children: Making the case for early preventive mental health services
83. Children of depressed parents: An integrative review
84. Maternal depressive symptoms affect infant cognitive development in Barbados
85. Mother-toddler interaction patterns associated with maternal depression
86. Effects of early maternal depression on patterns of infant-mother attachment: A meta-analytic investigation
87. Depressed mothers- and their infants-interactions with nondepressed partners
88. Maternal depression effects on infants and early interventions
89. The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: Genetic and maternal factors
90. Effect of neonatal handling on age-related impairments associated with the hippocampus
91. Effects of handling during infancy on the sympathetic-adrenal medullary system of rats
92. Maternal and environmental influences on the adrenocortical response to stress in weanling rats
93. Early handling and maternal behavior: Effect on d-amphetamine responsiveness in rats
94. Maternal behavior, pup vocalizations, and pup temperature changes following handling in mice of 2 inbred strains
95. Strain of foster mother determines long-term effects of early handling: Evidence for maternal mediation
96. Mother infant interaction and the modulation of pituitary-adrenal activity in rat pups after early stimulation
97. Positive effects of tactile vs. kinesthetic or vestibular stimulation on neuroendocrine and ODC activity in maternally deprived rat pups
98. Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: A putative role for corticotropin-releasing factor
99. The pituitary-adrenocortical system of neonatal rats is responsive to stress throughout development in a time-dependent and stressor-specific fashion
100. Early stress and genetic influences on hypothalamic-pituitary-adrenal axis functioning in adulthood
101. The neurobiology of posttraumatic stress disorder: An integration of animal and human research
102. Psychoneuroendocrinology of post-traumatic stress disorder
103. Hypothalamic-pituitary-adrenal functioning in post-traumatic stress disorder
104. The effects of varying environmental demands on maternal and infant behavior
105. Developmental consequences of altered dyadic coping patterns in bonnet macaques
106. Attachment in monkey infants raised in variable and low-demand environments
107. Relationship between foraging and affiliative social referencing in primates
108. Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions
109. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: Implications for the pathophysiology of mood and anxiety disorders
110. Interpersonal psychotherapy for depressed antepartum women: A pilot study
111. Efficacy of interpersonal psychotherapy for postpartum depression
112. Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects
113. Use of electroconvulsive therapy during pregnancy
114. Clinical strategies for the use of psychotropic drugs during pregnancy
115. Pharmacologic management of psychiatric illness in pregnancy: Dilemmas and guidelines
116. Treatment guidelines for psychotropic drug use in pregnancy
117. Psychotropic drug use in pregnancy
118. Teratogenicity of psychotherapeutic medications
119. Treatment of mental disorders in pregnancy: A review of psychotropic drug risks and benefits
120. Psychiatric medication during pregnancy: Understanding and minimizing the risks
121. The rational use of psychotropic drugs in pregnancy and postpartum
122. Depression in women: Recognition and treatment
123. Psychopharmacologic agents and electroconvulsive therapy during pregnancy and the puerperium
124. Risk-benefit decision making for treatment of depression during pregnancy
125. Breast-feeding and the use of psychotropic medication: A review
126. Antidepressant treatment during breast-feeding
127. Blockade by newly-developed antidepressants of biogenic amine uptake in rat brain synaptosomes
128. Binding of antidepressants to human brain receptors: Focus on newer antidepressants
129. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)
130. Neurodevelopment of children exposed in utero to antidepressant drugs
131. Effects of third trimester fluoxetine exposure on the newborn
132. Birth outcomes in pregnant women taking fluoxetine
133. Delivery outcome after the use of antidepressants in early pregnancy
134. Tricyclic dose requirements across pregnancy
135. Pharmacokinetics during pregnancy: Evidence-based maternal dose formulation
136. In vitro permeability of different layers of human placenta to carbohydrates and urea
137. Placental transfer of drugs administered to the mother
138. Controlling drug delivery across the placenta
139. Fluoxetine hydrochloride (Prozac) toxicity in a neonate
140. Paroxetine withdrawal syndrome in a neonate
141. Suspected congenital sertraline dependence
142. Fetal exposure to SERT antagonist antidepressants in rats
143. Blockade by newly-developed antidepressants of biogenic amine uptake in rat brain synaptosomes
144. Binding of antidepressants to human brain receptors: Focus on newer antidepressants
145. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites
146. Citalopram and desmethylcitalopram in breast milk and in serum of mother and infant
147. Stereoselective excretion of fluoxetine and norfluoxetine in breast milk and neonatal exposure
148. Possible association between fluoxetine hydrochloride and colic in an infant
149. Fluoxetine in breast-milk and developmental outcome of breast-fed infants
150. Maternal use of psychotropics during lactation: Quantifying infant exposure
151. Excretion of fluvoxamine in breast milk
152. Paroxetine in breast milk and nursing infants
153. Sertraline and desmethylsertraline in human breast milk and nursing infants
154. Sertraline and norsertraline levels in three breastfed infants
155. Serum sertraline and NBdesmethylsertraline levels in breast-feeding mother-infant pairs
156. Sertraline and breast feeding
157. Breast feeding and sertraline: A 24 hour analysis
158. Citalopram and breast-feeding: Serum concentration and side effects in the infant
159. Possible association between fluoxetine hydrochloride and colic in an infant
160. Treatment issues during pregnancy and lactation